Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-18.09%
↓ 132% vs avg
Percentile
P17
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
56.72%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -18.09% |
| Q3 2025 | 10.28% |
| Q2 2025 | 12.39% |
| Q1 2025 | 4.01% |
| Q4 2024 | -17.28% |
| Q3 2024 | 16.59% |
| Q2 2024 | 13.22% |
| Q1 2024 | -6.77% |
| Q4 2023 | -1.05% |
| Q3 2023 | 16.40% |
| Q2 2023 | -2.60% |
| Q1 2023 | -8.99% |
| Q4 2022 | -43.69% |
| Q3 2022 | 30.84% |
| Q2 2022 | -110.83% |
| Q1 2022 | 2198.65% |
| Q4 2021 | 156.93% |
| Q3 2021 | -5.28% |
| Q2 2021 | 21.05% |
| Q1 2021 | -37.46% |
| Q4 2020 | -572.25% |
| Q3 2020 | 81.82% |
| Q2 2020 | -25.97% |
| Q1 2020 | 11.49% |
| Q4 2019 | -7.91% |
| Q3 2019 | -13.93% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |